Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Recurrence, Local × Talaporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 2 Neoplasm Recurrence, Local 1 Neoplasm Metastasis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

tislelizumab 1 motexafin gadolinium 1 Tamoxifen 1 Talaporfin 1 Radiotherapy 1 Lomustine 1 Irinotecan 1 Folfox protocol 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00440310 2015-08-25

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Light Sciences Oncology

Phase 3 Completed

483 enrolled 7 charts

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡